Cardiovascular effects of the aqueous extract from Caesalpinia ferrea: Involvement of ATP-sensitive potassium channels

Vascular Pharmacology

Volumn 47, Issue 1, 2007, Pages 41-47

  Menezes, Igor A C ^a   Moreira, Ítalo J A ^a   Carvalho, Adriana A ^a   Antoniolli, Angelo R ^a   Santos, Márcio R V ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

Aqueous extract; ATP sensitive K+ channel; Caesalpinia ferrea; Cardiovascular effect; Rat

Indexed keywords

4 AMINOPYRIDINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ATROPINE; CAESALPINIA FERREA EXTRACT; GLIBENCLAMIDE; N(G) NITROARGININE METHYL ESTER; PHENYLEPHRINE; PLANT EXTRACT; POTASSIUM CHLORIDE; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; ATRIOVENTRICULAR BLOCK; BARK; BRADYCARDIA; CAESALPINIA; CAESALPINIA FERREA; CARDIOVASCULAR EFFECT; CHANNEL GATING; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE COMPARISON; EXTRASYSTOLE; HYPOTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; TACHYCARDIA; TRADITIONAL MEDICINE; VASODILATATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ATROPINE; BLOOD PRESSURE; CAESALPINIA; ELECTROCARDIOGRAPHY; HEART RATE; MALE; MESENTERIC ARTERY, SUPERIOR; NG-NITROARGININE METHYL ESTER; PLANT EXTRACTS; POTASSIUM CHANNELS; RATS;

EID: 34249659071     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.03.005     Document Type: Article

References (33)

1. Aguilar-Bryan L., Bryan J., and Nakazaki M. Of mice and men: K(ATP) channels and insulin secretion. Recent Prog. Horm. Res. 56 (2001) 47-68
2. Bachi E.M., Sertie J.A.A., Villa N., and Katz H. Antiulcer action and toxicity of Styrax camporum and Caesalpinia ferrea. Planta Med. 61 (1995) 204-207
3. Bernheim A., Fatio R., Kiowski W., Weilenmann D., Rickli H., and Rocca H.P. Atropine often results in complete atrioventricular block or sinus arrest after cardiac transplantation: an unpredictable and dose-independent phenomenom. Transplantation 77 (2004) 1181-1185
4. Bragança L.A.R. Plantas Medicinais Antidiabéticas (1996), EDUFF press, Niterói, RJ 172
5. Campbell W.B., Gebremedhin D., Prait P.F., and Herder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78 (1996) 415-423
6. Carr R.D., Brand C.L., Bodvarsdottir T.B., Hansen J.B., and Sturis J. NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rat. Diabetes 52 (2003) 2513-2518
7. Carvalho J.C.T., Teixeira J.R.M., Souza P.J.C., Bastos J.K., Filho D.S., and Sarti S.J. Preliminary studies of analgesic and anti-inflammatory properties of Caesalpinia ferrea crude extract. J. Ethnopharmacol. 53 (1996) 175-178
8. Cirigliano M., and Sun A. Advising patients about herbal therapies. JAMA 280 (1998) 1565-1566
9. Damiano B.P., Stump G.L., Cheung W.M., and Salata J.J. In vivo cardiac electrophysiologic effects of RWJ 29009, a new potassium-channel activator, in comparison to cromakalim and nicardipine. J. Cardiovasc. Pharmacol. 22 (1993) 146-152
10. Eisenberg D.M., Davis R.B., and Ettner S.L. Trends in alternative medicine use in the United States. JAMA 280 (1998) 1569-1575
11. Fluckiger J.P., Sonnay N., Boillat N., and Atkinson J. Attenuation of the baroreceptor reflex by general anesthetic agent in normotensive rat. Eur. J. Pharmacol. 109 (1985) 105-109
12. Fugh-Berman A. Herb-drug interactions. Lancet 355 (2000) 134-138
13. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
14. Gonzalez F.G., Barros S.B.M., and Bachi E.M. Atividade antioxidante e perfil fitoquímico de Caesalpinia ferrea MART. Braz. J. Pharm. Sci. 40 supl 1 (2004) 79
15. Gotanda K., Satoh K., and Taira N. Is the cardiovascular profile of BRL 34915 characteristic of potassium channels activators?. J. Cardiovasc. Pharmacol. 12 (1988) 239-246
16. Guldstrand M., Grill V., Bjorklund A., Lins P.E., and Adamson U. Improved beta cell function after short-term treatment with diazoxide in obese subjects with type 2 diabetes. Diabetes Metab. 28 (2002) 448-456
17. Jackson W.F. Íon channels and vascular tone. Hypertension 35 (2000) 173-178
18. Jahangir A., and Terzic A. KATP channel therapeutics at the bedside. J. Mol. Cell. Cardiol. 39 (2005) 99-112
19. Lagaud G.J., Skarsgard P.L., Laher I., and Van Breemen C. Heterogeneity of endothelium-dependent vasodilation in pressurized cerebral and small mesenteric resistance arteries of the rat. J. Pharmacol. Exp. Ther. 290 (1999) 832-839
20. Langton P.D., Nelson M.T., Huang Y., and Standen N.B. Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am. J. Physiol. 260 (1991) H927-H934
21. Mayer G.G., and Kaelin P.B. Arrhythmias and cardiac output. Am. J. Nurs. 72 (1972) 1597-1600
22. Moncada S., and Higgs E.A. The l-ariginine-nitric oxide pathway. N. Engl. J. Med. 29 (1993) 2002-2012
23. Mulvany M.J., and Aalkjaer C. Structure and function of small arteries. Physiol. Rev. 70 (1990) 921-961
24. Murashev A.N., Rzhevskii D.I., Korshunov V.A., and Lobanov A.V. Arrhythmogenic effects of endothelin-1 under conditions of NO-synthase blockade with l-NAME in NMRI mice. Bull. Exp. Biol. Med. 135 (2003) 370-373
25. Nakamura E.S., Kurosaki F., Arisawa M., Mukainaka T., Takayasu J., Okuda M., Tokuda H., Nishino H., and Pastore F. Cancer chemopreventive effects of a Brazilian folk medicine, Juca, on in vivo two-stage skin carcinogenesis. J. Ethnopharmacol. 81 (2002) 135-137
26. Nelson M.T., and Quayle J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 268 (1995) C799-C822
27. Rang H.P., Dale M.M., Ritter J.M., and Moore M.C. Pharmacology. 5th ed. (2003), Elsevier, United Kingdom
28. + channel openers, a class of drugs with vasorelaxant and cardioprotective properties. Life Sci. 47 (1990) 1693-1705
29. Smith T.L., and Hutchins P.M. Anaesthetic effects on hemodynamics os spontaneously hypertensive and Wistar-Kyoto rats. Am. J. Physiol. 238 (1980) H539-H544
30. Sobey C.G. Potassium channels function in the vascular disease. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 28-38
31. Sowton E. Hemodynamic consequences of arrhythmias. J. Cardiovasc. Pharmacol. 17 Supl 6 (1991) S20-S23
32. Vora C.K., and Mansoor G.A. Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases. Curr. Hypertens. Rep. 7 (2005) 275-280
33. White R.M., Rivera C.O., and Davison C.B. Differential contribution of endothelial function to vascular reactivity in conduit and resistance arteries from deoxycorticosterone-salt hypertensive rats. Hypertension 27 (1996) 1245-1253